dz

dz dz

sq 中文
电话 0731-85681666-8006

dz

1
current position：
Homepage
/
发展历程
/
Approved Drugs
/
On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved

On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved

  • Categories:Approved Drugs
  • Author:
  • Origin:
  • Time of issue:2021-11-29 17:42
  • Views:

On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved

  • Categories:Approved Drugs
  • Author:
  • Origin:
  • Time of issue:2021-11-29 17:42
  • Views:
Previous: Congratulations to Sanjin Group Hunan Sanjin Pharmaceutical Co., LTD. Lamotrigine tablets the second national review!
Next: On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved
Previous: Congratulations to Sanjin Group Hunan Sanjin Pharmaceutical Co., LTD. Lamotrigine tablets the second national review!
Next: On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved

Online

Online

TEL

0731-85681666-8006

WeChat

WeChat

TOP

搜索
Search
dz

Service Hotline：

0731-85681666-8006

Copyright © 2021 Changsha Duxact Biotech Co., Ltd.     湘ICP备 16006884号-1
www.300.cn      Changsha